Effects of morphine on P2Y12 platelet inhibitors in patients with acute myocardial infarction: A meta-analysis

Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size

(2018) Mohamed Farag et al.   THROMBOSIS AND HAEMOSTASIS

Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention

(2018) Iosif Xenogiannis et al.   THROMBOSIS AND HAEMOSTASIS

Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine

(2018) Frédéric Lapostolle et al.   American Journal of Cardiovascular Drugs

Morphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction

(2017) Hye Bin Gwag et al.   PLoS One

Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction

(2017) Ulrike Flierl et al.   THROMBOSIS AND HAEMOSTASIS

The on- and off-target effects of morphine in acute coronary syndrome: A narrative review

(2016) Cian P. McCarthy et al.   AMERICAN HEART JOURNAL

Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients

(2016) Jolanta M. Siller-Matula et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

P2Y12Receptor Antagonists and Morphine

(2016) Georgios Giannopoulos et al.   Circulation-Cardiovascular Interventions

Morphine use and myocardial reperfusion in patients with acute myocardial infarction treated with primary PCI

(2016) Benedetta Bellandi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

(2016) Glenn N. Levine et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme

(2015) Etienne Puymirat et al.   EUROPEAN HEART JOURNAL

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

(2015) Jacek Kubica et al.   EUROPEAN HEART JOURNAL

Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2015) Francesco Franchi et al.   JACC-Cardiovascular Interventions

Double-Blind, Randomized, Prospective Comparison of Loading Doses of 600 mg Clopidogrel Versus 60 mg Prasugrel in Patients With Acute ST-Segment Elevation Myocardial Infarction Scheduled for Primary Percutaneous Intervention

(2015) Uwe Zeymer et al.   JACC-Cardiovascular Interventions

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients

(2013) Guido Parodi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Morphine Decreases Clopidogrel Concentrations and Effects

(2013) Eva-Luise Hobl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2012) et al.   EUROPEAN HEART JOURNAL

Cardioprotective Role of Remote Ischemic Periconditioning in Primary Percutaneous Coronary Intervention

(2010) Ilias Rentoukas et al.   JACC-Cardiovascular Interventions